2-(2-Chloro-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 500mg

tert-butyl N-[(1S,2S)-1-[methoxy(methyl)carbamoyl]-2-methylbutyl]carbamate, 95.0%, 1g

1-O-tert-Butyl 6-O-methyl 3,4-dihydro-2H-1,5-naphthyridine-1,6-dicarboxylate, 95+%, 250mg

(S)-3-AMINO-4,4,4-TRIFLUOROBUTAN-1-OL, 95.0%, 250mg

3,5-Dichloro-4-fluorobenzenemethanol, 100mg

4-Fluoro-1H-indole-7-carbonitrile, 95.0%, 1g

1-decyl-3-methylimidazolium hexafluorophosphate, 99.0%, 5g

Trial kit Spectra/Por® 1-3 Spectra/Por® 3 - MWCO 3500, 54 mm, 1 Piece(s)

2,4-Dibromo-5-methoxybenzoic acid, 95%, 250mg

N-(4-Hydroxyphenyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 97%, 100mg

Hederacoside C, ROTICHROM® Working Standard, 25 mg, glass packaging

1,2-Benzenedimethanol, 95.0%, 500g

2,6-Diiodo-4-(trifluoromethyl)aniline, 95+%, 5g